Please read and agree to the terms and conditions of this site.
@xconomy.com 4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@ccn.com 5 years ago
Dow Recoils as UnitedHealth Boss Bashes Medicare for All
@xconomy.com 5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More